Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Evidence-based pharmacogenetic guidelines in the netherlands
- In: Poster presentation
- At: Seoul (South Korea) (2017)
- Type: Poster
- Poster code: POS-SAPS-011
- By: CHEUNG, Ka-Chun (Royal Dutch Pharmacists Association, Medicine Information Centre, DEN HAAG, Netherlands)
- Co-author(s): Ka-Chun Cheung:
Marga Nijenhuis: Medicine Information Centre, Royal Dutch Pharmacists Association, DEN HAAG, Netherlands
Mandy Crommentuijn – van Rhenen: Medicine Information Centre, Royal Dutch Pharmacists Association, DEN HAAG, Netherlands
Inge Holsappel: Medicine Information Centre, Royal Dutch Pharmacists Association, DEN HAAG, Netherlands
Scientific studies have shown that genetic variation in genes encoding drug transporters and drug metabolic enzymes affects drug disposition leading to under-dosing or overdosing in individuals. Therefore, application of pharmacogenetics may improve both drug safety and efficacy.
In 2005 the Royal Dutch Pharmacists Association The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019